HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nitin Kaila Selected Research

Retinal Vein Occlusion

11/2014Pharmacokinetics of ranibizumab after intravitreal administration in patients with retinal vein occlusion or diabetic macular edema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nitin Kaila Research Topics

Disease

1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2021
1Neoplasms (Cancer)
07/2021
1Hypercholesterolemia
05/2015
1Retinal Vein Occlusion
11/2014
1Macular Edema
11/2014

Drug/Important Bio-Agent (IBA)

1Rituximab (Mabthera)FDA Link
07/2021
1Biosimilar PharmaceuticalsIBA
07/2021
1insulin receptor-related receptor (IRR)IBA
07/2021
1LDL CholesterolIBA
05/2015
1oxidized low density lipoproteinIBA
05/2015
1Proprotein Convertase 9IBA
05/2015
1Monoclonal AntibodiesIBA
05/2015
1bococizumabIBA
05/2015
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2015
1Ranibizumab (Lucentis)FDA Link
11/2014